A citation-based method for searching scientific literature

Subba R Digumarthy, Dexter P Mendoza, Jessica J Lin, Tianqi Chen, Marguerite M Rooney, Emily Chin, Lecia V Sequist, Jochen K Lennerz, Justin F Gainor, Alice T Shaw. Clin Lung Cancer 2020
Times Cited: 14







List of co-cited articles
81 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Imaging characteristics of BRAF-mutant non-small cell lung cancer by functional class.
Dexter P Mendoza, Ibiayi Dagogo-Jack, Tianqi Chen, Atul Padole, Jo-Anne O Shepard, Alice T Shaw, Subba Rao Digumarthy. Lung Cancer 2019
13
61

ROS1 rearrangements define a unique molecular class of lung cancers.
Kristin Bergethon, Alice T Shaw, Sai-Hong Ignatius Ou, Ryohei Katayama, Christine M Lovly, Nerina T McDonald, Pierre P Massion, Christina Siwak-Tapp, Adriana Gonzalez, Rong Fang,[...]. J Clin Oncol 2012
57

Imaging Features and Metastatic Patterns of Advanced ALK-Rearranged Non-Small Cell Lung Cancer.
Dexter P Mendoza, Jessica J Lin, Marguerite M Rooney, Tianqi Chen, Lecia V Sequist, Alice T Shaw, Subba R Digumarthy. AJR Am J Roentgenol 2020
11
63

Diffuse Lung Metastases in EGFR-Mutant Non-Small Cell Lung Cancer.
Subba R Digumarthy, Dexter P Mendoza, Atul Padole, Tianqi Chen, P Gabriel Peterson, Zofia Piotrowska, Lecia V Sequist. Cancers (Basel) 2019
10
70

Computed Tomography Imaging Characteristics of Non-Small-Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements: A Systematic Review and Meta-Analysis.
Dexter P Mendoza, Justin Stowell, Alona Muzikansky, Jo-Anne O Shepard, Alice T Shaw, Subba R Digumarthy. Clin Lung Cancer 2019
14
42

Clinicopathologic and Imaging Features of Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
Subba R Digumarthy, Dexter P Mendoza, Eric W Zhang, Jochen K Lennerz, Rebecca S Heist. Cancers (Basel) 2019
16
42

Decoding Tumor Phenotypes for ALK, ROS1, and RET Fusions in Lung Adenocarcinoma Using a Radiomics Approach.
Hyun Jung Yoon, Insuk Sohn, Jong Ho Cho, Ho Yun Lee, Jae-Hun Kim, Yoon-La Choi, Hyeseung Kim, Genehee Lee, Kyung Soo Lee, Jhingook Kim. Medicine (Baltimore) 2015
75
35

The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib.
Tejas Patil, Derek E Smith, Paul A Bunn, Dara L Aisner, Anh T Le, Mark Hancock, William T Purcell, Daniel W Bowles, D Ross Camidge, Robert C Doebele. J Thorac Oncol 2018
62
35

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
Manabu Soda, Young Lim Choi, Munehiro Enomoto, Shuji Takada, Yoshihiro Yamashita, Shunpei Ishikawa, Shin-ichiro Fujiwara, Hideki Watanabe, Kentaro Kurashina, Hisashi Hatanaka,[...]. Nature 2007
35

Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene.
Takayuki Fukui, Yasushi Yatabe, Yoshihisa Kobayashi, Kenji Tomizawa, Simon Ito, Shunzo Hatooka, Keitaro Matsuo, Tetsuya Mitsudomi. Lung Cancer 2012
88
35

Sclerotic Bone Metastasis in Pulmonary Adenocarcinoma.
Riyadh Ali Mohammed Hammamy, Khalid Farooqui, Wisam Ghadban. Case Rep Med 2018
8
50

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.
Klarisa Rikova, Ailan Guo, Qingfu Zeng, Anthony Possemato, Jian Yu, Herbert Haack, Julie Nardone, Kimberly Lee, Cynthia Reeves, Yu Li,[...]. Cell 2007
28

From genotype to phenotype: Are there imaging characteristics associated with lung adenocarcinomas harboring RET and ROS1 rearrangements?
Andrew J Plodkowski, Alexander Drilon, Darragh F Halpenny, Dearbhail O'Driscoll, Donald Blair, Anya M Litvak, Junting Zheng, Chaya S Moskowitz, Michelle S Ginsberg. Lung Cancer 2015
19
28

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.
Daisy Wing-Sze Wong, Elaine Lai-Han Leung, Kimpton Kam-Ting So, Issan Yee-San Tam, Alan Dart-Loon Sihoe, Lik-Cheung Cheng, Kwok-Keung Ho, Joseph Siu-Kie Au, Lap-Ping Chung, Maria Pik Wong. Cancer 2009
541
28

ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases.
Akihiko Yoshida, Takashi Kohno, Koji Tsuta, Susumu Wakai, Yasuhito Arai, Yoko Shimada, Hisao Asamura, Koh Furuta, Tatsuhiro Shibata, Hitoshi Tsuda. Am J Surg Pathol 2013
115
28

Imaging Features and Patterns of Metastasis in Non-Small Cell Lung Cancer with RET Rearrangements.
Subba R Digumarthy, Dexter P Mendoza, Jessica J Lin, Marguerite Rooney, Andrew Do, Emily Chin, Beow Y Yeap, Alice T Shaw, Justin F Gainor. Cancers (Basel) 2020
9
44

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.
Solange Peters, D Ross Camidge, Alice T Shaw, Shirish Gadgeel, Jin S Ahn, Dong-Wan Kim, Sai-Hong I Ou, Maurice Pérol, Rafal Dziadziuszko, Rafael Rosell,[...]. N Engl J Med 2017
21

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.
Stefania Rizzo, Francesco Petrella, Valentina Buscarino, Federica De Maria, Sara Raimondi, Massimo Barberis, Caterina Fumagalli, Gianluca Spitaleri, Cristiano Rampinelli, Filippo De Marinis,[...]. Eur Radiol 2016
148
21


Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study.
Benjamin J Solomon, Benjamin Besse, Todd M Bauer, Enriqueta Felip, Ross A Soo, D Ross Camidge, Rita Chiari, Alessandra Bearz, Chia-Chi Lin, Shirish M Gadgeel,[...]. Lancet Oncol 2018
319
21

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.
David S Ettinger, Dara L Aisner, Douglas E Wood, Wallace Akerley, Jessica Bauman, Joe Y Chang, Lucian R Chirieac, Thomas A D'Amico, Thomas J Dilling, Michael Dobelbower,[...]. J Natl Compr Canc Netw 2018
301
21

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi, Shunichi Sugawara, Satoshi Oizumi, Hiroshi Isobe, Akihiko Gemma, Masao Harada, Hirohisa Yoshizawa, Ichiro Kinoshita,[...]. N Engl J Med 2010
21

Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers.
Alexander Drilon, Jessica J Lin, Thomas Filleron, Ai Ni, Julie Milia, Isabella Bergagnini, Vaios Hatzoglou, Vamsidhar Velcheti, Michael Offin, Bob Li,[...]. J Thorac Oncol 2018
61
21

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Jean-Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata,[...]. N Engl J Med 2018
21

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non-Small-Cell Lung Cancer.
Justin F Gainor, Diane Tseng, Satoshi Yoda, Ibiayi Dagogo-Jack, Luc Friboulet, Jessica J Lin, Harper G Hubbeling, Leila Dardaei, Anna F Farago, Katherine R Schultz,[...]. JCO Precis Oncol 2017
129
21

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
Alice T Shaw, Beow Y Yeap, Mari Mino-Kenudson, Subba R Digumarthy, Daniel B Costa, Rebecca S Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott,[...]. J Clin Oncol 2009
21

Novel targets in non-small cell lung cancer: ROS1 and RET fusions.
Justin F Gainor, Alice T Shaw. Oncologist 2013
221
21

Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R Aberle, Amanda M Adams, Christine D Berg, William C Black, Jonathan D Clapp, Richard M Fagerstrom, Ilana F Gareen, Constantine Gatsonis, Pamela M Marcus, JoRean D Sicks. N Engl J Med 2011
21

ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases.
Arne Warth, Thomas Muley, Hendrik Dienemann, Benjamin Goeppert, Albrecht Stenzinger, Philipp A Schnabel, Peter Schirmacher, Roland Penzel, Wilko Weichert. Histopathology 2014
76
21

Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.
A T Shaw, G J Riely, Y-J Bang, D-W Kim, D R Camidge, B J Solomon, M Varella-Garcia, A J Iafrate, G I Shapiro, T Usari,[...]. Ann Oncol 2019
118
21



Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.
Yi-Long Wu, James Chih-Hsin Yang, Dong-Wan Kim, Shun Lu, Jianying Zhou, Takashi Seto, Jin-Ji Yang, Noboru Yamamoto, Myung-Ju Ahn, Toshiaki Takahashi,[...]. J Clin Oncol 2018
137
21

MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression.
Mark M Awad, Geoffrey R Oxnard, David M Jackman, Daniel O Savukoski, Dimity Hall, Priyanka Shivdasani, Jennifer C Heng, Suzanne E Dahlberg, Pasi A Jänne, Suman Verma,[...]. J Clin Oncol 2016
344
14


Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutations.
Samantha X Y Wang, Li Lei, Haiwei H Guo, Joseph Shrager, Christian A Kunder, Joel W Neal. Lung Cancer 2018
4
50

Anchored multiplex PCR for targeted next-generation sequencing.
Zongli Zheng, Matthew Liebers, Boryana Zhelyazkova, Yi Cao, Divya Panditi, Kerry D Lynch, Juxiang Chen, Hayley E Robinson, Hyo Sup Shim, Juliann Chmielecki,[...]. Nat Med 2014
514
14

Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial.
David Planchard, Egbert F Smit, Harry J M Groen, Julien Mazieres, Benjamin Besse, Åslaug Helland, Vanessa Giannone, Anthony M D'Amelio, Pingkuan Zhang, Bijoyesh Mookerjee,[...]. Lancet Oncol 2017
412
14

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.
Alice T Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, Takashi Seto, Lucio Crinó, Myung-Ju Ahn, Tommaso De Pas, Benjamin Besse, Benjamin J Solomon, Fiona Blackhall,[...]. N Engl J Med 2013
14

Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?
Subba R Digumarthy, Atul M Padole, Roberto Lo Gullo, Lecia V Sequist, Mannudeep K Kalra. Medicine (Baltimore) 2019
38
14

MET Exon 14 Skipping in Non-Small Cell Lung Cancer.
Rebecca S Heist, Hyo Sup Shim, Shalini Gingipally, Mari Mino-Kenudson, Long Le, Justin F Gainor, Zongli Zheng, Martin Aryee, Junfeng Xia, Peilin Jia,[...]. Oncologist 2016
63
14

Crizotinib in ROS1-rearranged non-small-cell lung cancer.
Alice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, D Ross Camidge, Benjamin J Solomon, Ravi Salgia, Gregory J Riely, Marileila Varella-Garcia, Geoffrey I Shapiro, Daniel B Costa,[...]. N Engl J Med 2014
14

ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
Al Charest, Erik W Wilker, Margaret E McLaughlin, Keara Lane, Ram Gowda, Shanie Coven, Kevin McMahon, Steven Kovach, Yun Feng, Michael B Yaffe,[...]. Cancer Res 2006
107
14

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
Jeffrey A Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, Youngchul Song, Courtney Hyland, Joon Oh Park, Neal Lindeman, Christopher-Michael Gale, Xiaojun Zhao, James Christensen,[...]. Science 2007
14

An overview of the c-MET signaling pathway.
Shawna Leslie Organ, Ming-Sound Tsao. Ther Adv Med Oncol 2011
434
14

Evolution of treatment strategies for oligometastatic NSCLC patients - A systematic review of the literature.
Daniel H Schanne, Jana Heitmann, Matthias Guckenberger, Nicolaus H J Andratschke. Cancer Treat Rev 2019
22
14

KIF5B-RET fusions in lung adenocarcinoma.
Takashi Kohno, Hitoshi Ichikawa, Yasushi Totoki, Kazuki Yasuda, Masaki Hiramoto, Takao Nammo, Hiromi Sakamoto, Koji Tsuta, Koh Furuta, Yoko Shimada,[...]. Nat Med 2012
562
14

An unusual case of pulmonary adenocarcinoma with multiple and extraordinary metastases.
Hamid Reza Haghighatkhah, Morteza Sanei Taheri, Seyed Mohammad Hadi Kharrazi, Damoon Ghazanfari Amlashi, Mehrnoosh Haddadi, Mahin Pourabdollah. Iran J Radiol 2012
4
50

Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial.
Alexander Drilon, Natasha Rekhtman, Maria Arcila, Lu Wang, Andy Ni, Melanie Albano, Martine Van Voorthuysen, Romel Somwar, Roger S Smith, Joseph Montecalvo,[...]. Lancet Oncol 2016
260
14

Recent Advances in Targeting ROS1 in Lung Cancer.
Jessica J Lin, Alice T Shaw. J Thorac Oncol 2017
121
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.